Quantcast

Jury blames Vioxx for man's heart attack, awards $47.5 million

TRENTON, N.J. — Merck & Co.'s painkiller Vioxx contributed to an Idaho postal worker's heart attack, a jury in Atlantic City ruled Monday, reversing the verdict in the man's first trial and hitting Merck with a total of $47.5 million in damages.